ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $76,977 | -62.3% | 48,413 | +47.8% | 0.00% | – |
| Q4 2022 | $204,002 | +5.7% | 32,745 | +13.6% | 0.00% | – |
| Q3 2022 | $193,000 | -8.1% | 28,818 | -12.8% | 0.00% | – |
| Q2 2022 | $210,000 | +47.9% | 33,030 | +8.6% | 0.00% | – |
| Q1 2022 | $142,000 | +65.1% | 30,425 | +77.5% | 0.00% | – |
| Q4 2021 | $86,000 | -62.4% | 17,141 | -9.9% | 0.00% | – |
| Q3 2021 | $229,000 | -46.0% | 19,030 | -4.9% | 0.00% | – |
| Q2 2021 | $424,000 | -27.6% | 20,015 | -4.2% | 0.00% | – |
| Q1 2021 | $586,000 | +0.3% | 20,889 | -7.1% | 0.00% | – |
| Q4 2020 | $584,000 | -2.3% | 22,477 | +39.7% | 0.00% | – |
| Q3 2020 | $598,000 | -15.5% | 16,095 | +16.5% | 0.00% | -100.0% |
| Q2 2020 | $708,000 | -87.4% | 13,816 | -92.3% | 0.00% | -80.0% |
| Q1 2020 | $5,641,000 | -51.8% | 178,935 | -8.9% | 0.01% | -37.5% |
| Q4 2019 | $11,714,000 | +41.3% | 196,476 | -13.1% | 0.01% | +33.3% |
| Q3 2019 | $8,291,000 | -52.4% | 226,208 | -39.6% | 0.01% | -40.0% |
| Q2 2019 | $17,426,000 | +149.7% | 374,624 | +115.4% | 0.01% | +150.0% |
| Q1 2019 | $6,980,000 | +1169.1% | 173,895 | +1353.4% | 0.00% | – |
| Q4 2018 | $550,000 | -93.4% | 11,965 | -93.6% | 0.00% | -100.0% |
| Q3 2018 | $8,308,000 | -7.9% | 187,289 | -18.7% | 0.00% | -33.3% |
| Q2 2018 | $9,022,000 | -24.1% | 230,241 | +40.0% | 0.00% | -50.0% |
| Q1 2018 | $11,892,000 | +2.8% | 164,440 | -6.5% | 0.01% | -14.3% |
| Q4 2017 | $11,571,000 | +95.7% | 175,787 | +49.0% | 0.01% | +75.0% |
| Q3 2017 | $5,912,000 | -23.9% | 117,987 | -29.7% | 0.00% | -33.3% |
| Q2 2017 | $7,768,000 | -28.1% | 167,872 | -45.2% | 0.01% | -25.0% |
| Q1 2017 | $10,808,000 | +613.9% | 306,160 | +152.9% | 0.01% | +700.0% |
| Q4 2016 | $1,514,000 | -59.4% | 121,060 | -55.1% | 0.00% | -66.7% |
| Q3 2016 | $3,731,000 | +69.6% | 269,509 | +20.9% | 0.00% | +50.0% |
| Q2 2016 | $2,200,000 | -70.3% | 222,867 | -49.2% | 0.00% | -66.7% |
| Q1 2016 | $7,412,000 | -29.2% | 438,459 | -6.8% | 0.01% | -14.3% |
| Q4 2015 | $10,468,000 | -9.1% | 470,295 | -3.6% | 0.01% | -22.2% |
| Q3 2015 | $11,510,000 | -14.1% | 488,018 | +197.7% | 0.01% | 0.0% |
| Q2 2015 | $13,402,000 | -15.1% | 163,934 | -3.8% | 0.01% | -10.0% |
| Q1 2015 | $15,781,000 | +173.5% | 170,444 | +19.5% | 0.01% | +150.0% |
| Q4 2014 | $5,769,000 | +109.5% | 142,683 | +26.7% | 0.00% | +100.0% |
| Q3 2014 | $2,754,000 | +54.7% | 112,647 | +0.2% | 0.00% | +100.0% |
| Q2 2014 | $1,780,000 | +4350.0% | 112,452 | +4066.4% | 0.00% | – |
| Q1 2014 | $40,000 | -91.3% | 2,699 | -91.9% | 0.00% | – |
| Q4 2013 | $458,000 | -76.8% | 33,383 | -68.1% | 0.00% | -100.0% |
| Q3 2013 | $1,974,000 | – | 104,777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |